Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma

Published:2019-04-12 Issue:4 Volume:14 Page:e0215295
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Giagnuolo Giovanna,Buffardi Salvatore,Rossi Francesca,Petruzziello Fara,Tortora Chiara,Buffardi Isabella,Marra Nicoletta,Beneduce Giuliana,Menna Giuseppe,Parasole Rosanna^ORCID

Funder

Associazione Italiana Contro le Leucemie Sezione Bruno Rotoli Napoli

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting;N Bougamin;Cur Oncol,2012

2. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009;K Jordan;Support Care Cancer

3. Antiemetics: American Society of Clinical Oncology Practice Guideline Update;E Basch;J Clin Oncol,2011

4. Product Monograph,2017

5. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability;L Gore;Pediatr Blood Cancer,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

2. Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients;Journal of Clinical Medicine;2023-03-09

3. A scoping review of nausea, vomiting and retching measurement methods in children with cancer;Pediatrics & Neonatology;2022-07

4. In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease;Molecular Diversity;2021-07-31

5. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?;Cancers;2020-09-20